Free tool
FAERS Monitor: Noxafil
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 205596 or its brand name (Noxafil, Posaconazole). Reports on generic versions are filed under their own applications.
Reports
16,564
Serious
14,256
86% of reports
Hospitalization
7,340
Death reported
3,927
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use1,706
- drug ineffective1,513
- febrile neutropenia1,099
- product use in unapproved indication1,074
- drug interaction1,042
- death993
- pyrexia921
- neutropenia770
- pneumonia698
- thrombocytopenia551
- diarrhoea550
- nausea536
- acute kidney injury462
- septic shock461
- condition aggravated449
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 3 |
| 2005 | 22 |
| 2006 | 33 |
| 2007 | 113 |
| 2008 | 116 |
| 2009 | 154 |
| 2010 | 115 |
| 2011 | 182 |
| 2012 | 249 |
| 2013 | 249 |
| 2014 | 407 |
| 2015 | 503 |
| 2016 | 631 |
| 2017 | 930 |
| 2018 | 1,101 |
| 2019 | 1,229 |
| 2020 | 1,363 |
| 2021 | 1,534 |
| 2022 | 1,529 |
| 2023 | 1,576 |
| 2024 | 1,684 |
| 2025 | 1,671 |
| 2026 | 1,170 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,037,595 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| febrile neutropeniaSignal | 1,099 | 21.4 | 20.2 | 21,037 |
| septic shockSignal | 461 | 13.6 | 12.4 | 5,318 |
| drug interactionSignal | 1,042 | 8.4 | 7.9 | 6,781 |
| neutropeniaSignal | 770 | 7.2 | 6.7 | 4,128 |
| thrombocytopeniaSignal | 551 | 6.3 | 5.8 | 2,443 |
| product use in unapproved indicationSignal | 1,074 | 5.5 | 5.2 | 4,003 |
| acute kidney injurySignal | 462 | 3.8 | 3.5 | 973 |
| pyrexiaSignal | 921 | 3.4 | 3.2 | 1,568 |
| pneumoniaSignal | 698 | 2.7 | 2.5 | 781 |
| off label useSignal | 1,706 | 2.5 | 2.4 | 1,563 |
| condition aggravated | 449 | 1.9 | 1.7 | 185 |
| death | 993 | 1.5 | 1.4 | 152 |
| drug ineffective | 1,513 | 1.5 | 1.4 | 232 |
| diarrhoea | 550 | 1.1 | 1.0 | 3 |
| nausea | 536 | 0.9 | 0.8 | 13 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.